Chemistry Reference
In-Depth Information
5.
Scanlon , K.J. ; Kashani - Sabet , M. ; Miyachi , H. ; C. Sowers , L. ; Rossi , J. ; Molecular basis of
cisplatin resistance in human carcinomas: Model systems and patients;
Anticancer Res.
,
1989 ,
9
, 1301 - 1312 .
Perez , R.P. ; Hamilton , T.C. ; Ozols , R.F. ; Young , R.C.; Mechanisms and modulation of
resistance to chemotherapy in ovarian cancer;
Cancer
, 1993 ,
71
, 1571 - 1580 .
Safaei , R. ; Holzer , A.K. ; Katano , K. ; Samimi , G. ; Howell , S.B. ; The role of copper trans-
porters in the development of resistance to Pt drugs;
J. Inorg. Chem.
, 2004 ,
98
,
1607 - 1613 .
Samimi , G. ; Safaei , R. ; Katano , K. ; Holzer , A.K. ; Rochdi , M. ; Tomioka , M. ; Goodman ,
M. ; Howell , S.B. ; Increased expression of the copper effl ux transporter ATP7A mediates
resistance to cisplatin, carboplatin and oxaliplatin in ovarian cancer cells;
Clin. Cancer
Res.
, 2004 ,
10
, 4661 - 4669 .
Holford , J. ; Beale , P.J. ; Boxall , F.E. ; Sharp , S.Y. ; Kelland , L.R. ; Mechanisms of drug resist-
ance to the platinum complex ZD0473 in ovarian cancer cell lines;
Eur. J. Cancer
, 2000 ,
36
, 1984 - 1990 .
Yang , P. ; Ebbert , J.O. ; Sun , Z. ;
6.
7.
8.
9.
10.
Weinshilboum , R.M. ; Role of the glutathione metabolic
pathway in lung cancer treatment and prognosis: a review;
J. Clin. Oncol.
, 2006 ,
24
,
1761 - 1769 .
Ferry , K.V. ; Hamilton , T. C. ; Johnson , S.V. ; Increased nucleotide excision repair in cispla-
tin-resistant ovarian cancer cells: role of ERCC1- XPF ;
Biochem. Pharmacol.
, 2000 ,
60
,
1305 - 1313 .
Chang , Y.J. ; Kim , M.H. ; Kim , H.B. ; Lee , D.Y. ; Kim , S.H. ; Kim , H.Y. ; You , H.J. ; Small
interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer
cells to cisplatin;
Biochem. Biophys. Res. Commun.
, 2005 ,
327
, 225 - 233 .
Reed , E.; ERCC1 and clinical resistance to platinum- based therapy ;
Clin. Cancer Res.
,
2005 ,
11
, 6100 - 6102 .
Fink , D. ; Nebel , S. ; Aebi , S. ; Zheng , H. ; Cenni , B. ; Nehm é , A. ; Christen , R.D. ;
11.
12.
13.
14.
Howell ,
S.B.; The role of DNA mismatch repair in platinum drug resistance;
Cancer Res.
, 1996 ,
56
, 4881 - 4886 .
Bassett , E. ; Vaisman , A. ; Tropea , K.A. ; McCall , C.M. ; Masutani , C. ; Hanaoka , F. ; Chaney ,
G.; Frameshifts and deletions during
in vitro
translesion synthesis past Pt- DNA adducts
by DNA polymerases β and η ;
DNA Repair
, 2002 ,
1
, 1003 - 1016 .
Albertella , M.R. ; Green , C.M. ; Lehmann , A.R. ; O ' Connor , M.J. ; A role for polymerase
η in the cellular tolerance to cisplatin- induced
15.
16.
damage ;
Cancer Res.
,
2005 ,
65
,
9799 - 9806 .
White , S.C. ; Lorigan , P. ; Margison , G.P. ; Margison , J.M. ; Martin , F. ; Thatcher , N. ; Ander-
son , H. ; Ranson , M. ; Phase II study of SPI -77 (sterically stabilised liposomal cisplatin)
in advanced nonsmall cell lung cancer;
Br. J. Cancer
, 2006 ,
92
, 822 - 828 .
Dragovich , T. ; Mendelson , D. ; Kurtin , S. ; Richardson , K. ; Von Hoff , D. ; Hoos , A. ; A phase
2 trial of the liposomal DACH platinum L-NDDP in patients with therapy- refractory
advanced colorectal cancer;
Cancer Chemoter. Pharmacol.
, 2006 ,
58
, 759 - 764 .
Rademaker - Lakhai , J.M. , Terret , C. ; Howell , S.B. ; Baud , C.M. ; De Boer , R.F. ; Pluim , D. ;
Beijnen , J.H. ; Schellens , J.H. ; Droz, J.P.; A phase I and pharmacological study of the
platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in
patients with solid tumours;
Clin. Cancer Res.
, 2004 ,
10
, 3386 - 3395 .
Rice , J.R. ; Gerberich , J.L. ; Nowotnik , D.P. ; Howell , S.B. ; Preclinical effi cacy and pharma-
cokinetics of AP5346, a novel diaminocyclohexane-platinum tumourtargeting drug
delivery system;
Clin. Cancer Res.
, 2006 ,
12
, 2248 - 2254 .
Campone , M. ; Rademaker - Lakhai , J.M. , Bennouna , J. ; Howell , S.B. ; Nowotnik , D.P. ;
Beijnen , J.H. ; Schellens , J.H. ; Phase I and pharmacokinetic trial of AP5346, a DACH-
platinum-polymer conjugate, administered weekly for three out of every 4 weeks to
advanced solid tumour patients;
Chemoter. Pharmacol.
, 2007 ,
60
, 523 - 533 .
Armstrong , D.K. ; Bundy , B. ; Wenzel , L. ; Huang , H.Q. ; Baergen , R. ; Lele , S. ; Copeland ,
L.J. ; Walker , J.L. ; Burger , R.A. ; Gynecologic Oncology Group; Intraperitoneal cisplatin
and paclitaxel in ovarian cancer;
N. Engl. J. Med.
, 2006 ,
354
, 34 - 43 .
17.
18.
19.
20.
21.
22.
